SCHEMBL9604817

SCHEMBL9604817

CC(C)(C)OC(=O)C#CCCCl

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.33
FAAH O00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29060117 0.89 SPHK1 (0.33) CTSK
SCHEMBL1089166 0.82 SPHK1 (0.35) CTSK
SCHEMBL27546342 0.80 CTSK (0.33) CTSK
SCHEMBL13926370 0.78 DGAT1 (0.32) CTSK
SCHEMBL1088319 0.78 SPHK1 (0.42) CTSK
SCHEMBL15418773 0.77 TDP1 (0.43) CTSK
SCHEMBL1088806 0.77 CTSK (0.35) CTSK
SCHEMBL27014757 0.77 CTSK (0.35) CTSK
Iodide SCHEMBL7205304 0.76 SPHK1 (0.33) CTSK
SCHEMBL1100128 0.76 SPHK1 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135980-A1 GAMMA SECRETASE MODULATORS SCHERING CORPORATION 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135980-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, GSAP CTSK 140/4885FAAH 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.